74 related articles for article (PubMed ID: 2838557)
1. [Killer T cell activity specific to Epstein-Barr virus in patients with uterine cervical cancer].
Kitano Y; Fujisaki S; Okamura H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):647-8. PubMed ID: 2838557
[No Abstract] [Full Text] [Related]
2. Immunological disorder against the Epstein-Barr virus infection and prognosis in patients with cervical carcinoma.
Kitano Y; Fujisaki S; Nakamura N; Miyazaki K; Katsuki T; Okamura H
Gynecol Oncol; 1995 May; 57(2):150-7. PubMed ID: 7537239
[TBL] [Abstract][Full Text] [Related]
3. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
[TBL] [Abstract][Full Text] [Related]
4. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
5. Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus.
Felton SC; Hoffmann CC; Kreier JP; Glaser R
Lab Anim Sci; 1984 Apr; 34(2):164-8. PubMed ID: 6328114
[TBL] [Abstract][Full Text] [Related]
6. Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens.
Seeley J; Svedmyr E; Weiland O; Klein G; Moller E; Eriksson E; Andersson K; van der Waal L
J Immunol; 1981 Jul; 127(1):293-300. PubMed ID: 6263974
[No Abstract] [Full Text] [Related]
7. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.
Kimura H; Hoshino Y; Hara S; Sugaya N; Kawada J; Shibata Y; Kojima S; Nagasaka T; Kuzushima K; Morishima T
J Infect Dis; 2005 Feb; 191(4):531-9. PubMed ID: 15655776
[TBL] [Abstract][Full Text] [Related]
8. [Herpesvirus hominis type 2 and Epstein-Barr virus antibodies in patients with cancer of the uterine cervix].
Vestergaard BF; Hornsleth A; Pedersen SN
Ugeskr Laeger; 1973 Jul; 135(27):1425-8. PubMed ID: 4357007
[No Abstract] [Full Text] [Related]
9. [Chronic Epstein-Barr virus infection].
Imashuku S; Teramura T
Nihon Rinsho; 2005 Apr; 63 Suppl 4():503-7. PubMed ID: 15861702
[No Abstract] [Full Text] [Related]
10. Natural killer lymphocyte function in cervical cancer patients.
Pulay TA; Benczur M; Varga M
Neoplasma; 1982; 29(2):237-40. PubMed ID: 7110449
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cellular immune response to EBV by using cloned T cell lines.
Slovin SF; Schooley RT; Thorley-Lawson DA
J Immunol; 1983 May; 130(5):2127-32. PubMed ID: 6187840
[TBL] [Abstract][Full Text] [Related]
12. Immunobiology of HPV Infection.
Garcia-Chacon R; Velasco-Ramirez SF; Flores-Romo L; Daneri-Navarro A
Arch Med Res; 2009 Aug; 40(6):443-8. PubMed ID: 19853184
[No Abstract] [Full Text] [Related]
13. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
14. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
Hammer MH; Brestrich G; Mittenzweig A; Roemhild A; Zwinger S; Subklewe M; Beier C; Kurtz A; Babel N; Volk HD; Reinke P
J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
[TBL] [Abstract][Full Text] [Related]
15. [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection].
Konno M
Hokkaido Igaku Zasshi; 1989 Mar; 64(2):125-38. PubMed ID: 2543617
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
Kaplan J; Shope TC
Nat Immun Cell Growth Regul; 1985; 4(1):40-7. PubMed ID: 2993873
[TBL] [Abstract][Full Text] [Related]
17. Long-term T-cell-mediated immunity to Epstein-Barr virus.
Rickinson AB; Moss DJ; Wallace LE; Rowe M; Misko IS; Epstein MA; Pope JH
Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
[No Abstract] [Full Text] [Related]
18. Generation of long-term human cytolytic cell lines with persistent natural killer activity.
Krensky AM; Ault KA; Reiss CS; Strominger JL; Burakoff SJ
J Immunol; 1982 Oct; 129(4):1748-51. PubMed ID: 6286775
[TBL] [Abstract][Full Text] [Related]
19. Imbalance of the Epstein-Barr virus-host relationship in AIDS-related complex patients.
Ragona G; Sirianni MC
Cancer Detect Prev Suppl; 1987; 1():549-52. PubMed ID: 2826004
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between natural cytotoxicity activity, Epstein-Barr virus (EBV) antibody titer and clinical status in nasopharyngeal carcinoma patients].
Mu M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(1):46-9. PubMed ID: 2856431
[No Abstract] [Full Text] [Related]
[Next] [New Search]
